147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Use of ngal inhibitors for treating chronic wound

Chronic wounds and in particular diabetic ulcers are a serious complication of diabetes. Unresolved inflammation, associated with the dysregulation of […]

Recombinant flagellin for preventing and treating

The present invention relates to the use of an optimized truncated flagellin (TLR5 agonist devoided of toxic effect) for preventing or treating […]

Histone chaperone hira inhibitor for treating hepatitis b virus

The present invention concerns an inhibitor for use for preventing and/or treating an infection with hepatitis B virus (HBV) and an in vitro screening […]

Methods and topical pharmaceutical compositions for the treatment of

Microvascular dysfunction remains a major contributor to the development of skin complications. The inventors assessed the impact of the local […]

Inhibitors of the pp1/gadd34 complex for the treatment of a condition

The present invention relates to the general field of the treatment and prevention of diseases involving an inflammatory condition, namely sepsis or […]

Prophylactic hiv vaccine

The invention relates to mAb based chimeric proteins allowing direct in-vivo targeting of antigens to the dendritic cells. GMP manufacturing of a […]

M-csf for preventing or treating myeloid cytopenia and related

The invention relates to a method for preventing or treating myeloid cytopenia and related complications such as infections in patients undergoing […]

Rankl to boost thymic regeneration

Cytoablative treatments lead to severe damages on thymic epithelial cells (TECs), which result in delayed de novo thymopoïesis and a prolonged period […]

Fonctionalized microparticules as vaccination adjuvant and ag vector

The invention relates to microparticules fonctionalized with alphagalactosylceramide for sustained iNKT cell activation. Delivering of […]

Ptgdrs, cxcr4 and basophils in systemic lupus erythematosus

The present invention relates to PTGDRs, CXCR4 and Basophils to treat in Systemic Lupus Erythematosus. In particular, the present invention concerns a […]

More posts

You might also be interested in